2.60
前日終値:
$2.66
開ける:
$2.66
24時間の取引高:
455.19K
Relative Volume:
0.73
時価総額:
$155.69M
収益:
-
当期純損益:
$-40.33M
株価収益率:
-1.4525
EPS:
-1.79
ネットキャッシュフロー:
$-39.53M
1週間 パフォーマンス:
-24.42%
1か月 パフォーマンス:
-23.98%
6か月 パフォーマンス:
-42.09%
1年 パフォーマンス:
-4.41%
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
名前
Eledon Pharmaceuticals Inc
セクター
電話
949-238-8090
住所
19800 MACARTHUR BLVD., IRVINE
ELDN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ELDN
Eledon Pharmaceuticals Inc
|
2.60 | 159.29M | 0 | -40.33M | -39.53M | -1.79 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-18 | 再開されました | H.C. Wainwright | Buy |
2025-01-28 | 開始されました | Guggenheim | Buy |
2022-05-13 | 再開されました | Cantor Fitzgerald | Overweight |
2021-03-23 | 開始されました | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc (ELDN) 最新ニュース
Published on: 2025-08-13 08:17:22 - Newser
Real time alert setup for Eledon Pharmaceuticals Inc. performance2025 Trading Recap & Daily Stock Trend Reports - Newser
Can Eledon Pharmaceuticals Inc. rally from current levelsDividend Hike & AI Forecast for Swing Trade Picks - Newser
Can Eledon Pharmaceuticals Inc. hit a new high this monthJuly 2025 Institutional & Low Risk Entry Point Tips - Newser
Statistical indicators supporting Eledon Pharmaceuticals Inc.’s strengthQuarterly Trade Review & Risk Controlled Daily Plans - Newser
Eledon Pharmaceuticals Inc. stock outlook for YEARTrade Risk Report & Expert Approved Momentum Trade Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving today [Trade Exit Summary]Free High Accuracy Swing Trade Signals - Newser
Custom watchlist performance reports with Eledon Pharmaceuticals Inc.Price Movement and Market Sentiment Analysis - Newser
Can trapped investors hope for a rebound in Eledon Pharmaceuticals Inc.2025 Volatility Report & Community Shared Stock Ideas - Newser
How to recover losses in Eledon Pharmaceuticals Inc. stockFree Trend Following Strategy With Stop Loss - Newser
Combining price and volume data for Eledon Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
How Eledon Pharmaceuticals Inc. stock performs during market volatilityFree Multi-Bagger Potential Stock Forecast Tools - Newser
Detecting support and resistance levels for Eledon Pharmaceuticals Inc.Free Oversold Bounce Stock Play Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving todayLow-Risk Reversal Pattern Analysis Tracker - Newser
Published on: 2025-08-10 22:59:19 - Newser
The week in pharma: action, reaction and insight – week to August 8 - The Pharma Letter
Using Bollinger Bands to evaluate Eledon Pharmaceuticals Inc.Bear Market Safe Zone Technical Analysis - Newser
Has Eledon Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewFree Trade Timing Strategy With Technical Data - Newser
Is Eledon Pharmaceuticals Inc. stock a good hedge against inflationTrade Plan With Low Risk High Return - Newser
Volatility clustering patterns for Eledon Pharmaceuticals Inc.Free High Return Stock Focus With Safety - Newser
Should you hold or exit Eledon Pharmaceuticals Inc. nowFree Access to Real-Time Trade Insights - Newser
Using portfolio simulators with Eledon Pharmaceuticals Inc. includedEarly Entry Ideas with Momentum Potential - Newser
Order flow analysis tools used on Eledon Pharmaceuticals Inc.Watchlist Generator With Real-Time Entry - Newser
Eledon Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Chart-Based Forecast for Traders - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
Ipsen is no longer advancing Sutro’s ADC; Layoffs at Tune Therapeutics - Endpoints News
Eledon Pharmaceuticals shares rise 2.37% after-hours following updated Phase Ib data conference call. - AInvest
Mixed market reaction to Eledon Phase Ib trial for tegoprubart - The Pharma Letter
Eledon Plunges 17.15% on Clinical Trial Data, Oracle Rumors - AInvest
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals - TipRanks
Eledon Pharmaceuticals shares fall 9.88% premarket despite positive Phase 1b trial data for tegoprubart. - AInvest
Eledon Pharmaceuticals Reports Promising Phase 1b Trial Results - TipRanks
Eledon Pharmaceuticals Inc (ELDN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):